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gens, but each of them is also an absolutely unique the view that Listeria is a Gram-negative enterobacte-
combination of virulence factors. Even more, some of rium disguised as a Gram-positive bacterium. Although
the common virulence mechanisms may be used in dif- this second part of the book compares pathogens like
ferent contexts and generate different, if not antagonis- every Medical Microbiology textbook has done since
tic, effects in the host. This is nicely exemplified by type the origins of Microbiology, it is nevertheless absolutely
III secretion, which triggers the internalization of certain essential. Forgetting this part and concentrating only on
bacteria by nonphagocytic cells, while it protects other mechanisms may indeed lead to major medical confu-
bacteria from phagocytosis! Clearly, pathogenic bacte- sions since similar molecular mechanisms can contrib-
ria contribute to the diversity of Mother Nature. There- ute to syndromes as different as meningitis and diarrhea.
fore, there is no alternative for a book but to deal with My only regret for this part of the book is the omission
each genus of pathogenic bacteria separately. In short, of a great number of bacterial pathogens, including top
writing a comprehensive book about the infection’s biol- killers like Mycobacterium tuberculosis or Neisseria
ogy or, more simply, about current state of Medical meningitidis. Atypical bacteria like Chlamydia, Ricket-
Microbiology, is a tough challenge. tsia, Bartonella, and Borrelia are unfortunately also
Jo¨rg Hacker and Ju¨rgen Heesemann took up this chal- missing in this part, although they are cited on several
lenge, and they did it very well. First, they made the occasions in the general part. Of course, space is always
wise decision to introduce first the general concepts a limit, but then, one may wonder why Toxoplasma gon-
and mechanisms and then to describe individually a dii and Candida albicans found their place. Also, readers
number of pathogens. Let us first consider the general should be warned that in spite of the general title of the
part. This part begins with a reminder of the host- book, they will not find any virus description. Viruses
defense mechanisms. Although it is a good synthesis, only appear in lists of agents causing the various infec-
some readers may think that the chapter devoted to the tious syndromes. This is, perhaps, unfortunate because
inflammatory reaction could have been more thorough. the discovery of numerous bacterial virulence effectors
This section also includes some basic Cell Biology pro- has brought bacteria and viruses a lot closer.
cesses like signal transduction, cytoskeleton dynamics, In conclusion, this is an excellent Medical Microbiol-
and apoptosis, which are classical targets for patho- ogy textbook, certainly among the best available today.
genic bacteria. This was again a good decision. Then Without any hesitation, I would recommend it to every
comes a description of the pathogenicity mechanisms. medical student, to every Ph.D. student who contributes
To make a rather long list easier to cope with, they came to this blooming field, and also to you, life scientist, if
up with the idea of dividing pathogenicity factors into your last Microbiology course dates from more than 10
two categories: “offensive” (e.g., invasins and toxins) years ago.
and “defensive” (e.g., capsules and molecular mimicry).
Major offensive systems like type III secretion and im-
Guy R. Cornelisportant defensive systems like antigenic variation each
Biozentrumreceived each their own full chapter. A separate chapter
University of Baselis dedicated to the regulation of the expression of viru-
CH-4056 Basellence genes. All the basic regulatory mechanisms in-
Switzerlandvolved in the control of virulence functions are clearly
described. An effort has been made to synthesize and
illustrate very complex regulatory networks such as the
C Is for CFTR, M Is for Mdr,one orchestrating the synthesis of fimbriae. There is a
whole chapter devoted to the sophisticated methodol- S is for Ste6—The Alphabet
ogy that has been developed to capture the in vivo of ABC Proteins
behavior of the pathogens (signature tag mutagenesis,
in vivo expression technology, etc.). This part of the
book is excellent and gives a nice flavor of Microbiology
ABC Proteins: From Bacteria to Manas a discipline addressing questions and extracting con-
Edited by I.B. Holland, S.P.C. Cole, K. Kuchler,cepts. It avoids being simplistic and it also avoids the
and C.F. Higginsvery common pitfalls of being deterministic. The basic
London: Academic Press/Elsevier Science (2003).Darwinian concepts are indeed often forgotten in some
647 pp. $179.95flamboyant descriptions of bacterial “strategies”! The
first part of the book also contains a chapter dealing
with the new molecular diagnostic tools and a small
Whether one studies recycling of visual pigments in thechapter dealing with antibiotics and antibiotic resis-
retina, the growing problem of resistance to antimalarialtance. The reason for the inclusion of this “crash de-
drugs, or import of amino acids into bacterial cells, thescription” of a huge field is not obvious. The minor criti-
chances are more than good that an ABC protein iscisms that I have to this part of the book are that more
involved. The editors of ABC Proteins: From Bacteriaexperiments could have been described and that all
to Man have valiantly attempted to encompass in thisthe illustrations are in black and white. Future editions
volume the entire scope of research on these proteins,deserve color illustrations.
from atomic-resolution structure to human genetic dis-The second part of the book, about one-third of the
eases, and from Escherichia coli to Homo sapiens andtotal, describes individual pathogens. Interestingly
Arabidopsis thaliana. This endeavor is somewhat auda-enough, the authors treat Listeria in the same chapter
as Shigella, Salmonella, and Yersinia, somehow taking cious because there are well over 2000 ABC proteins
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known but fewer than 625 pages of text. The book begins ing CFTR), Stargardt’s disease (caused by mutations in
ABCR/ABCA4), Tangier disease (caused by mutationswith general phylogenetic information, then devotes
several chapters to structure and function analysis, fol- in ABCA1), and pseudoxanthoma elasticum (caused by
mutations in ABCC6). Indeed, although the best under-lowed by chapters dealing with ABC proteins in different
organisms, and finishes with a number of chapters about stood ABC proteins fall into the first two classes to be
discovered (bacterial nutrient importers and eukaryotichuman ABC proteins. The breadth of coverage is impres-
sive, and the authors of the different chapters bring a drug exporters), there may not be an area of biology
devoid of them. As the book enumerates, ABC proteinsvariety of perspectives to bear. Thus, the book provides
a thorough introduction to almost all aspects of ABC are present in every sequenced genome, and full or
partial cDNAs for many more are available from organ-proteins and, despite the unavoidable lag between writ-
ing and publication, manages to discuss emerging isms whose genomes have not yet been sequenced. S.
cerevisiae encodes some 30 recognizable ABC proteins,points of interest.
What the book makes obvious is that nearly all ABC the human genome 48, and A. thaliana a staggering 129.
Nor are ABC proteins rare in other kingdoms: E. coliproteins are membrane localized, ATP dependent, pri-
mary active transporters. ABC transporters consist of encodes 78, and available archaeal genome sequences
encode as many as 40. Thus, ABC proteins are trulyfour units (which can be separate proteins or all in one
polypeptide): two domains with multiple membrane- universal components of all extant living things.
Unfortunately, ubiquitous does not mean tractablespanning segments and two domains that bind nucleo-
tide (or ATP-binding cassettes, from whence came the and, like other membrane proteins, ABC transporters
have proven challenging to study. Bacterial and mam-ABC designation). ABC domains not only comprise con-
served sequence elements required for binding and hy- malian transporters are covered in the greatest detail in
the book because they have been studied longest anddrolysis of ATP, including the Walker A and B motifs
(Walker, J.E., Saraste, M., Runswick, M.J., and Gray, N.J. are better understood than ABC proteins in other organ-
isms. Nonetheless, decades after their discovery, a clear[1982]. EMBO J. 1, 945–951.), but also other conserved
sequence elements unique to this superfamily, such as mechanistic picture of how the ABC engine powers ac-
tive transport has not emerged, nor is it possible tothe so-called signature motif (LSGGQ). Some ABC trans-
porters have additional domains, and the superfamily predict what compound a given transporter recognizes
on the basis of its primary sequence alone. Even moreincludes proteins with ABC domains that are associated
not with active transport, but with processes like regula- obscure are how and to what processes the ABC pro-
teins involved in translation and DNA repair harnesstion of translation or repair of DNA damage. However,
very little information is presented in the book about the ATP binding and hydrolysis. Despite the difficulties in
applying in vitro methods to understand mechanism andlatter classes of ABC proteins.
As the book recounts, the first mutations in what are structure/function relationships in such proteins, the
book documents that good progress has been madenow known to be ABC transporters were isolated in
Drosophila in the early twentieth century by virtue of over the last 10 years, and such goals no longer seem so
distant. However, for the aficionado, more experimentalchanges in eye color. Bacterial permeases involved in
nutrient uptake and dependent on periplasmic substrate detail in the relevant chapters would have been wel-
come. Also, important aspects of ABC transporter re-binding proteins were first characterized in the 1960s
and thereafter shown to be ABC transporters. The first search, like folding and trafficking during biogenesis,
are dealt with only cursorily in the book.mammalian ABC transporter to be identified was the
P-glycoprotein (Pgp, now MDR1 or ABCB1) because its As the book illustrates, a landmark for this field was
determination of crystal structures for two isolated ABCpresence was associated with the striking pleiotropic
crossresistance to many other growth-inhibitory com- domains, each a component of a bacterial import sys-
tem: HisP (Hung, L.W., Wang, I.X., Nikaido, K., Liu, P.Q.,pounds displayed by CHO cell lines selected for resis-
tance to colchicine (Juliano, R.L., and Ling, V. [1976]. Ames, G.F., and Kim, S.H. [1998]. Nature 396, 703–707.)
and RbsA (Armstrong, S., Tabernero, L., Zhang, H., Her-Biochim. Biophys. Acta 455, 152–162.). The first eukary-
otic ABC transporter with a physiologically defined modson, M.A., and Stauffacher, P. [1998]. Pediatr. Pul-
monol. 17, 91–92.). This advance gave rise to immediatesubstrate was Ste6, a protein from the yeast, Saccharo-
myces cerevisiae, responsible for exporting the lipopep- controversy, as the HisP structure suggested modes of
ABC-domain dimerization and transporter assembly attide mating pheromone, a-factor (Kuchler, K., Sterne,
R.E., and Thorner, J. [1989]. EMBO J. 8, 3973–3984; odds with much data on mammalian ABC transporters,
like Pgp/Mdr1. Crystal structure of another ABC protein,McGrath, J.P., and Varshavsky, A. [1989]. Nature 340,
400–404.). Since these diverse beginnings, as the book Rad50 (Hopfner, K.-P., Karcher, A., Craig, L., Woo, T.T.,
Carney, J.P., and Tainer, J.A. [2001]. Cell 105, 473–485.),documents, ABC transporters have been implicated in
almost every aspect of cell biology—as ion channels, in suggested an alternative dimerization interface—particu-
larly, that each ABC domain in a dimer contributes toantigen presentation, in formation and excretion of bile,
in trafficking and homeostasis of phospholipids and ste- the active site of the other, with one active site formed
from the Walker A and B sequences of one domainrols, and in plant development, to give but a few exam-
ples. ABC proteins are clearly implicated in clinically and the signature motif of the second, and vice versa.
Subsequent kinetic and functional analysis of ABC do-relevant phenomena, ranging from multidrug resistance
of human tumors that confounds chemotherapy (con- mains altered by site-directed mutagenesis, including
crosslinking studies, supports the Rad50 model. Theferred by Mdr1 in some tissues, but by Mrp1 or ABCG2
in others) to heritable genetic diseases, such as cystic shared active site arrangement is further supported by
the observation that in some ABC transporter subfam-fibrosis (caused by mutations in the gene ABCC7 encod-
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ilies, one ABC domain has degenerate Walker motifs and expose them to the extracellular aqueous phase.
Support for both models has been obtained.but an intact signature sequence, while the other has
Other work presented in the book has begun to eluci-intact Walker motifs but a degenerate signature se-
date the structural changes accompanying the transportquence.
cycle. Transport studies carried out with purified, recon-These satisfying conclusions seemed to be negated
stituted drug transporters indicate that affinity for drugswhen the structure of the bacterial homodimeric lipid A
decreases during the transport cycle, consistent withexporter MsbA (Chang, G., and Roth, C.B. [2001]. Sci-
transport of the drug from a high-affinity site to a low-ence 293, 1793–1800.) was reported. In this structure,
affinity site. Low- and medium-resolution structures forthe two halves of the transporter dimerize across a nar-
Pgp/Mdr1 in the presence and absence of bound nucle-row interface at one end of the molecule with the ABC
otides have been determined by the group of Chris Hig-domains widely separated at the other end. However,
gins (Rosenberg, M.F., Verlarde, G., Ford, R.C., Martin,whether this view represents an active conformation
C., Berridge, G., Kerr, I.D., Callaghan, R., Schmidlin,or an unfortunate artifact of crystallization remains a
A., Wooding, C., Linton, K.J., and Higgins, C.F. [2001].question. Indeed, the following year, the crystal struc-
EMBO J. 20, 5615–5625.). In the absence of ATP, Pgpture for a bacterial importer, BtuCD, was described
assumes a structure with roughly 6-fold symmetry when(Locher, K.P., Lee, A.T., and Rees, D.C. [2002]. Science
viewed from the extracellular face. In the presence of296, 1091–1098.). To the relief of many, BtuCD exhibited
AMP-PNP, mimicking the ATP bound state, the structurea very different structure, with the two halves of the
shifts to a species with 3-fold symmetry, whereas trap-transporter interacting all along the axis of symmetry
ping with ADP and vanadate gives an intermediate 6-foldand the two ABC domains interacting in a manner very
symmetry. These results suggest that ATP binding,reminiscent of the Rad50 dimer. In fact, these insights
rather than hydrolysis, triggers the major conformationalhighlight the main weakness of the book, which stems
change associated with a change in drug affinity. ATPfrom the timing of its publication. Most chapters were
hydrolysis would then simply reset the transporter. Thewritten after the MsbA structure appeared but before
book also presents work with CFTR, an ABC proteinthe BtuCD structure, so a coherent, unitary discussion
that functions as an ATP-gated ion channel, that sup-of how a complete transporter is organized is not pre-
ports this hypothesis. The group of John Riordan hassented. Additional structures should help determine
demonstrated that CFTR can be gated by high concen-whether BtuCD or MsbA is the more valid model for a
trations of AMP-PNP or by ATP in the absence of Mg2functional ABC transporter, and whether different sub-
(required for ATP hydrolysis by all ABC proteins, includ-families will prove to have substantially different archi-
ing CFTR). Thus, ABC proteins are at last yielding totectures.
analysis of their structure and function, although theyIn addition to advances in our understanding of ABC
are not easy proteins to study mechanistically.transporter structure, several chapters in the book also
As this volume attests, deciphering the physiologicaldescribe progress that has been made in elucidating
roles of ABC proteins has also proven difficult, espe-the mechanism of transport. Early studies demonstrated
cially in organisms where genetic analysis is not readilythat photolabile ATP derivatives crosslink to the ABC
available. Even where a clear-cut phenotype can bedomains, whereas transport substrates crosslink to the
attributed to a defect in an ABC transporter, establishingmembrane-spanning domains. Photo crosslinking stud-
a connection between that phenotype, a molecular func-ies and steady-state ATPase assays both show that
tion, and identity of the transport substrate can be prob-vanadate is an effective inhibitor of ATP hydrolysis by
lematic because the link between observed phenotypeABC domains and serves as a convenient agent to trap
and nature of the transport substrate may not be obvi-intermediates in the reaction cycle. A hallmark of many
ous. For example, although analysis of Pgp/Mdr1 hasdrug exporters of the ABC family is the ability to trans-
established a clear relationship between substrate (anti-
port efficiently hundreds of structurally unrelated com-
cancer drugs), function (drug export), and phenotype
pounds with good efficiency. Work described in the
(drug-resistant cells when MDR1 is amplified or overex-
book suggests that the wide spectrum of transport sub- pressed), the natural endogenous substrate(s) for Pgp/
strates stems, in part, from their hydrophobic nature Mdr1 remains unknown. Moreover, and in part for the
and consequent accumulation to high concentrations same reason, whether Pgp inhibitors can be success-
in biomembranes. Hence, the apparent affinity for drug fully applied to enhance the potency and effectiveness
based on its concentration in the total volume of the of antitumor agents remains uncertain. For many other
reaction is misleading. This situation allows a binding ABC transporters, the links between phenotype, func-
pocket with an appropriate hydrophobic cavity to ac- tion, and physiologically relevant substrate are even
commodate many drugs in slightly different modes, as more opaque. For example, mutations in ABCC6 cause
has been observed recently for the unrelated, broad- pseudoxanthoma elasticum, but the molecular function
specificity, drug efflux pump, AcrB from E. coli (Yu, E.W., and substrates of ABCC6 are unknown, and data indi-
McDermott G., Zgurskaya, H.I., Nikaido, H., and Kosh- cate that ABCC6 is not even expressed in the affected
land, D.E., Jr. [2003]. Science 300, 976–980.). These con- tissues! Nonetheless, because each sequenced ge-
siderations also led to proposals, described in the book, nome provides a complete inventory of the ABC proteins
that certain ABC proteins act as flippases (moving hy- for that organism, understanding the biological roles
drophobic compounds from one leaflet of a membrane that ABC proteins play is progressing. The book de-
to the other). ABC transporters that function as drug scribes a number of examples of transporters whose
exporters, by contrast, must move hydrophobic sub- existence was only uncovered through genome se-
quencing that now have known or suspected functions.stances from the inner leaflet of the plasma membrane
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Also, the advent of microarray analysis makes it possible other academic jobs, such as the chapter on teaching.
The authors keep the book humorous by casting charac-to determine in what tissues each ABC transporter is
ters in various scenarios that most PIs will face in theexpressed, and the development of RNAi should now
first few years. Throughout the book, there are quotesmake it possible to determine the effects of knocking
that highlight major pieces of advice from establisheddown the expression of every member of the family in
scientists. In addition, a CD is included that suppliesthose tissues.
many useful forms, such as one for writing a CV andDespite the relatively minor shortcomings mentioned
one for outlining an NIH budget.above and the fact that the book would have benefited
Overall, the advice in the book is excellent and ade-from additional proofreading and could have been made
quately covers the three major areas of running the lab:even more useful by more extensive indexing, the vol-
people, money, and science. It is difficult to find glaringume unquestionably succeeds overall as an in-depth
omissions on any of the topics that are covered. Thesurvey of both the biology and the biochemistry of a
book starts with a discussion of how to obtain a job.ubiquitous and astoundingly diverse family of very com-
Sources to find job openings are outlined, and thereplex enzymes. Every group with an interest in these
are instructions on writing the key documents: a CV, aproteins should own a copy. Finally, this book makes a
research proposal, and a cover letter. Many questionsconvincing case that many laboratories that may not yet
that postdoctoral fellows have when they enter the jobsuspect it will soon have a much more abiding interest in
market are answered in this chapter. The only weaknessABC proteins.
of this chapter is that the authors fail to emphasize that
it is risky to attempt negotiations prior to having an
offer. For instance, the authors suggest using the firstNathan C. Rockwell and Jeremy Thorner
interview to closely evaluate the department, but theDepartment of Molecular and Cell Biology
only real priority on the interview is to convince theUniversity of California at Berkeley
faculty that you should be offered the job. In addition,Rm. 16, Barker Hall
the advice that candidates discuss the two-body prob-Berkeley, California 94720
lem on the first visit might not always have a favorable
outcome.
Once the job is secured, the PI needs to set up theHow to Successfully Start a Lab
lab and the book covers this next phase of organizing
the lab and purchasing equipment. The authors stress
that new PIs should negotiate with vendors, an impor-Academic Scientists at Work: Navigating
tant point even though new investigators may be reluc-the Biomedical Research Career
tant. Although there are many strategic suggestionsBy Jeremy M. Boss and Susan H. Eckert
about deciding when to start the job relative to tenureNew York: Kluwer Academic Publishers (2003).
and family issues, the book does not mention that some-250 pp. $34.95
times the start date cannot be controlled. For instance,
universities often fail to finish lab construction by a
promised date, or they require teaching at a certain
Scientists receive academic positions every year, but
time of year. Time management is reviewed, which may
are they trained for the job? The general responsibilities appear obvious, but the book provides some excellent
of a Principal Investigator (PI) include the supervision reminders. In addition, there are many valuable lab orga-
of science, money, and people. Although all PIs have a nizational tools supplied in the appendix, such as inven-
strong scientific background, most have not received tory and oligo databases. Although it may take time
any training in the other fundamental aspects of op- to organize databases when the lab starts, systematic
erating a lab. Academic science is one of the few profes- computerization will save lots of future time.
sions where money and people are managed with no Obtaining and managing funding are critical aspects
prior experience. Most PIs, therefore, learn by trial and of running a lab, and there is an excellent chapter de-
error, an approach that often leads to mistakes. How- voted to securing funding. The authors make the point
ever, since early decisions contribute to the long-term that junior PIs should carefully weigh the time and effort
success or failure of a lab, it is critical that new investiga- put into applying for a grant relative to the payoff. There-
tors make good decisions from the start. fore, the priority should be to obtain a federal grant since
New PIs are anxious about many issues, such as how it generally brings in the most money for the longest
to obtain funding and how to supervise personnel. period. One area that the book does not cover is the
These concerns are addressed in Academic Scientists issue of indirect costs. Most new investigators are con-
at Work, Navigating the Biomedical Research Career, a fused about what they are and whether they affect their
new book by Jeremy Boss and Susan Eckert that sup- ability to obtain funding. In addition, many of the grants
plies PIs with a crash course in running a lab. The book recommended by the book might not cover an institu-
covers the “junior” PI stage, from finding an academic tion’s indirect costs, so PIs should be sure that they are
position to attaining tenure. The following topics are allowed to apply for grants that do not fully cover indirect
covered: obtaining a job, setting up a lab, getting money, costs. There are also many young investigator awards
hiring personnel, being a faculty citizen, being a teacher, that are available to help junior PIs, but these are not
becoming a mentor, and getting promoted. The book is covered. An excellent source for this information is on
aimed at laboratory-based biomedical scientists at U.S. the web site www.grantsnet.com. The book carefully
outlines the basic steps of writing a grant, and the onlyinstitutions, although certain chapters are applicable to
